- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05185687
Public Support for COVID-19 Test Allocation
Race, Status, Vaccines, Tests, and Place: Public Attitudes and Support for Equitable COVID-19 Vaccine and Test Allocation
연구 개요
상태
상세 설명
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
District of Columbia
-
Washington, District of Columbia, 미국, 20006
- Harris Insights & Analytics
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Aged 18 years old or older, United States resident
Exclusion Criteria:
- None
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: First Come, First Served
Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "First Come, First Served" plan description. |
Respondents will view the following description of the plan: "Tests will be sent out in the order they are requested.
People who request tests the quickest will get them first, no matter where they live.
People who request tests later may not get any.
This strategy is also known as 'First Come, First Served.'"
|
|
실험적: Random
Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "Random" plan description. |
Respondents will view the following description of the plan: "People who request tests will be entered into a random drawing, like a sweepstakes or lottery.
Everyone who is in the drawing has the same chance of getting tests, no matter where they live, but some people may not get any tests."
|
|
실험적: Disadvantaged Priority & Random
Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "Disadvantaged Priority & Random" plan description. |
Respondents will view the following description of the plan: "Because COVID-19 has hit people living in disadvantaged areas of the country harder, a proportion of tests will be sent exclusively to people in these zip codes.
Planners will allocate 80% of the tests using a random drawing, like a sweepstakes or lottery.
Everyone who is in the drawing has the same chance of getting tests, no matter where they live.
The remaining 20% are set aside exclusively for the most disadvantaged areas, again allocated with a random drawing.
Some people may not get any tests.
But people living in disadvantaged areas are more likely to get them."
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Support for allocation plan
기간: 5 minutes
|
Self-reported degree of support for the plan, measured on a 5-point Likert scale ("strongly oppose" to "strongly support") that will be collapsed into 3 response categories ("oppose," "neutral," and "support") for analysis.
|
5 minutes
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Household-level test allocation preference
기간: 5 minutes
|
Preferred way of sending tests to households, measured as a binary choice between a fixed or variable (based on household size) number of tests per household.
|
5 minutes
|
|
Tests allocated to disadvantaged areas
기간: 5 minutes
|
Self-reported percentage of tests wanted to be sent to disadvantaged areas, measured as a continuous variable on a slider from 0% to 100% with increments of 0.1%.
This outcome will only be measured for respondents in the "Disadvantaged Priority & Random" condition.
|
5 minutes
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Alison M Buttenheim, PhD, MBA, University of Pennsylvania
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 848725
- #84525 (레지스트리 식별자: AsPredicted)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .